###begin article-title 0
The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction
###end article-title 0
###begin p 1
###xml 35 78 35 78 <email xmlns:xlink="http://www.w3.org/1999/xlink">bernhard.nieswandt@virchow.uni-wuerzburg.de</email>
CORRESPONDENCE Bernhard Nieswandt: bernhard.nieswandt@virchow.uni-wuerzburg.de
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 234 236 234 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 237 238 237 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 359 361 359 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 444 446 444 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 611 613 611 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 672 674 672 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 887 889 887 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1125 1127 1125 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
###xml 1220 1224 <span type="species:ncbi:10090">mice</span>
Platelet activation and aggregation are essential to limit posttraumatic blood loss at sites of vascular injury but also contributes to arterial thrombosis, leading to myocardial infarction and stroke. Agonist-induced elevation of [Ca2+]i is a central step in platelet activation, but the underlying mechanisms are not fully understood. A major pathway for Ca2+ entry in nonexcitable cells involves receptor-mediated release of intracellular Ca2+ stores, followed by activation of store-operated calcium (SOC) channels in the plasma membrane. Stromal interaction molecule 1 (STIM1) has been identified as the Ca2+ sensor in the endoplasmic reticulum (ER) that activates Ca2+ release-activated channels in T cells, but its role in mammalian physiology is unknown. Platelets express high levels of STIM1, but its exact function has been elusive, because these cells lack a normal ER and Ca2+ is stored in a tubular system referred to as the sarcoplasmatic reticulum. We report that mice lacking STIM1 display early postnatal lethality and growth retardation. STIM1-deficient platelets have a marked defect in agonist-induced Ca2+ responses, and impaired activation and thrombus formation under flow in vitro. Importantly, mice with STIM1-deficient platelets are significantly protected from arterial thrombosis and ischemic brain infarction but have only a mild bleeding time prolongation. These results establish STIM1 as an important mediator in the pathogenesis of ischemic cardio- and cerebrovascular events.
###end p 3
###begin p 4
D. Varga-Szabo and A. Braun contributed equally to this paper.
###end p 4
###begin p 5
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 401 402 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 427 428 427 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 509 510 509 510 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 515 516 515 516 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 612 613 612 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 801 802 801 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 807 808 807 808 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 834 836 834 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 935 937 935 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 979 981 979 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 996 997 996 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 999 1000 999 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 1084 1085 1084 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 1216 1218 1216 1218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1276 1277 1276 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 1278 1280 1278 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 1298 1300 1298 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 1368 1370 1368 1370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1451 1453 1451 1453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 1608 1610 1608 1610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 1662 1664 1662 1664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 1720 1722 1720 1722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 1822 1824 1822 1824 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1825 1826 1825 1826 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 1961 1963 1961 1963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 1306 1311 <span type="species:ncbi:9606">human</span>
###xml 1751 1755 <span type="species:ncbi:10090">mice</span>
Platelet activation and aggregation at sites of vessel wall injury is crucial to prevent posttraumatic blood loss, but it also causes precipitate diseases such as myocardial infarction and stroke, which are still leading causes of death and disability in industrialized countries (1). Inhibition of platelet function is an important strategy for the prevention and treatment of myocardial infarction (2) and, possibly, stroke (2, 3). Platelet activation is triggered by subendothelial collagens, thromboxane A2 (TxA2) and ADP released from activated platelets, and thrombin generated by the coagulation cascade (4). Although these agonists trigger different signaling pathways, all activate phospholipase Cs (PLCs), leading to the production of diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP3). IP3 induces the release of Ca2+ from the sarcoplasmatic reticulum (SR), which is thought to trigger the influx of extracellular Ca2+ by a mechanism known as store-operated Ca2+ entry (SOCE) (5, 6). In addition, DAG and some of its metabolites have been shown to induce non-SOCE (7). Stromal interaction molecule 1 (STIM1) is an SR/endoplasmic reticulum (ER)-resident protein necessary for the detection of ER Ca2+ depletion and the activation of SOC channels in T cells (8-10) and mast cells (11). In human T cells, the four transmembrane-domain protein Orai1 (Ca2+ release-activated channel modulator) appears to be the predominant SOC channel (12), but the C-terminal region of STIM1 also interacts with other SOC channel candidates, such as transient receptor potential channels (TRPCs) 1, 2, and 4 (13). In platelets, STIM1 is expressed at high levels (14) and may contribute to SOCE by interacting with TRPC1 (15). We recently reported that mice expressing an activating EF-hand mutant of STIM1 have elevated [Ca2+]i levels in platelets, macrothrombocytopenia, and a bleeding disorder, indicating a role for STIM1-dependent SOCE in platelet function (14). The importance of SOCE for platelet activation, hemostasis, and thrombosis, however, remains unknown, and the mechanisms underlying the process are not defined.
###end p 5
###begin title 6
RESULTS AND DISCUSSION
###end title 6
###begin p 7
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1</italic>
###xml 259 262 247 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 254 262 242 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 393 396 381 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 388 396 376 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 527 542 503 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A and B</xref>
###xml 612 620 588 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 684 692 660 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 1138 1145 1108 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 1243 1246 1213 1216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1238 1246 1208 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1274 1276 1244 1246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1354 1356 1324 1326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1408 1411 1366 1369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1403 1411 1361 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1456 1464 1414 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
###xml 1552 1555 1510 1513 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1547 1555 1505 1513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1563 1571 1521 1529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
###xml 1735 1737 1693 1695 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 127 131 <span type="species:ncbi:10090">Mice</span>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
To address the function of STIM1 in vivo, the Stim1 gene was disrupted in mice by insertion of an intronic gene trap cassette. Mice heterozygous for the STIM1-null mutation developed normally, whereas a majority (approximately70%) of mice lacking STIM1 (Stim1-/-) died within a few hours after birth. Marked cyanosis was noted before death, suggesting a cardiopulmonary defect. Surviving Stim1-/- mice exhibited marked growth retardation, achieving approximately50% of the weight of wild-type littermates at 3 and 7 wk of age (Fig. 1, A and B). Western blot analyses confirmed the absence of STIM1 in platelets (Fig. 1 C, top) and other tissues (not depicted). Blood platelet counts (Fig. 1 D), mean platelet volume, and expression levels of major platelet surface receptors, including glycoprotein (GP) Ib-V-IX, GPVI, CD9, and beta1 and beta3 integrins (not depicted) were normal, indicating that STIM1 is not essential for megakaryopoiesis or platelet production. Similarly, no differences were found in red blood cell counts, hematocrit, or the activated partial thromboplastin time, a method for the assessment of plasma coagulation (Table I). To determine if STIM1 has a role in platelet SOCE, we induced SOC influx in wild-type and Stim1-/- platelets with the SR/ER Ca2+ ATPase (SERCA) pump inhibitor thapsigargin (TG). Interestingly, TG-induced Ca2+ store release was reduced approximately60% in Stim1-/- platelets compared with wild-type controls (Fig. 1 E). Furthermore, subsequent TG-dependent SOC influx was almost completely absent in Stim1-/- cells (Fig. 1 E). This demonstrates for the first time that STIM1 is essential for SOCE in platelets and suggests that STIM1-dependent processes contribute to the regulation of Ca2+ store content in these cells.
###end p 7
###begin p 8
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Defective SOCE in Stim1-deficient platelets.</bold>
###xml 77 80 77 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 72 80 72 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 139 142 139 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 134 142 134 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 466 468 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 623 626 618 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 618 626 613 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 771 773 763 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 795 797 787 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 798 799 790 791 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 876 878 868 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 933 935 921 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 936 937 924 925 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 947 948 933 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1005 1007 991 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
###xml 953 957 <span type="species:ncbi:10090">mice</span>
Defective SOCE in Stim1-deficient platelets. (A) 5-wk-old wild-type and Stim1-/- littermates. (B) Body weights of wild-type (+/+) and Stim1-/- (-/-) mice. Values are mean +/- SD. ***, P < 0.001. (C) Western blot analyses of platelet lysates from mice with the indicated genotypes (top) or of mice transplanted with the indicated bone marrow (bottom). Stim1 was assessed using an antibody that can recognize the N-terminal region of the protein (GOK/Stim1; reference 11). An antibody to beta3 integrin served as control. Results from two individuals per group are shown. (D) Peripheral platelet counts in wild-type and Stim1-/- mice. Values are mean +/- SD. (E) Fura-2-loaded platelets were stimulated with 5 muM TG for 10 min, followed by the addition of extracellular Ca2+ and monitoring of [Ca2+]i. Representative measurements (left) and maximal increase in intracellular Ca2+ concentrations compared with baseline levels (Delta[Ca2+]i) +/- SD (n = 4 mice per group) before and after addition of 1 mM Ca2+ (right) are shown. **, P < 0.01; ***, P < 0.001.
###end p 8
###begin p 9
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 29 37 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
Hematology and hemostasis in Stim1-/- chimeras
###end p 9
###begin p 10
###xml 81 84 81 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 76 84 76 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
Erythrocyte counts per nanoliter and coagulation parameters for control and Stim1-/- chimeras are shown. Values are mean +/- SD of five mice for each genotype. aPTT, activated partial thromboplastin time; HCT, hematocrit; PT, prothrombin time; TCT, thrombin clotting time.
###end p 10
###begin title 11
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 24 32 24 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
Defective SOC influx in Stim1-/- platelets
###end title 11
###begin p 12
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 68 76 68 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 184 187 184 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 179 187 179 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 339 347 339 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 473 475 473 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 476 477 476 477 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 585 600 585 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, A and B</xref>
###xml 614 615 614 615 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 650 652 650 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 707 710 707 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 702 710 702 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 782 784 782 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 810 813 810 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 805 813 805 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 865 867 865 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 908 911 908 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 903 911 903 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 982 984 982 984 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
Because of the early mortality and pronounced growth retardation in Stim1-/- mice, all subsequent studies were performed with lethally irradiated wild-type mice transplanted with Stim1-/- or wild-type bone marrow. 4 wk after transplantation, platelet counts were normal and STIM1 deficiency in platelets was confirmed by Western blotting (Fig. 1 C, bottom). To determine the significance of defective SOCE for agonist-induced platelet activation, we assessed changes in [Ca2+]i in response to ADP, thrombin, a collagen-related peptide (CRP) that stimulates the collagen receptor GPVI (Fig. 2, A and B), and the TxA2 analogue U46619 (not depicted). Ca2+ release from intracellular stores was reduced in Stim1-/- platelets compared with control for all agonists, indicating reduced Ca2+ levels in stores in Stim1-/- cells. In the presence of extracellular calcium, Ca2+ influx was dramatically reduced in Stim1-/- platelets. Thus, STIM1-dependent SOCE is a crucial component of the Ca2+ signaling mechanism in platelets for all major agonists, and non-SOCE makes only a minor contribution, at least under the conditions tested.
###end p 12
###begin p 13
###xml 28 30 28 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 79 87 79 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 0 98 0 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Defective agonist-induced Ca<sup>2+</sup> signaling and aggregate formation under flow in <italic>Stim1<sup>&#8722;/&#8722;</sup></italic> platelets.</bold>
###xml 144 147 144 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 139 147 139 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 294 296 292 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 305 307 303 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 308 309 306 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 397 399 395 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 471 473 465 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 474 475 468 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 485 486 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 554 557 546 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 549 557 541 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 926 927 906 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 958 961 938 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 953 961 933 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1098 1100 1078 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 1307 1308 1285 1286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 491 495 <span type="species:ncbi:10090">mice</span>
###xml 932 936 <span type="species:ncbi:10090">mice</span>
###xml 1313 1317 <span type="species:ncbi:10090">mice</span>
Defective agonist-induced Ca2+ signaling and aggregate formation under flow in Stim1-/- platelets. Fura-2-loaded wild-type (black line) or Stim1-/- (gray line) platelets were stimulated with 0.1 U/ml thrombin, 10 muM ADP, or 10 mug/ml CRP in the presence of extracellular 1 mM EGTA or 0.5 mM Ca2+, and [Ca2+]i was monitored. Representative measurements (A) and maximal increase in intracellular Ca2+ concentrations compared with baseline levels before stimulus (Delta[Ca 2+]i) +/- SD (n = 4 mice per group; B) are shown. (C) Impaired aggregation of Stim1-/- platelets (gray lines) in response to CRP and collagen but not ADP and thrombin (recording time = 10 min). (D) Flow cytometric analysis of integrin alphaIIbbeta3 activation (binding of JON/A-PE; left) and degranulation-dependent P-selectin exposure (right) in response to 0.1 U/ml thrombin, 10 muM ADP, 10 mug/ml CRP, and 1 mug/ml convulxin. Results are means +/- SD (n = 6 mice per group). (E) Stim1-/- platelets in whole blood fail to form stable thrombi when perfused over a collagen-coated (0.2 mg/ml) surface at a shear rate of 1,700 s-1. (top) Representative phase-contrast images. (bottom) Mean surface coverage (left) and relative platelet deposition as measured by the integrated fluorescent intensity per square millimeter (right) +/- SD (n = 4 mice). ***, P < 0.001. Bar, 100 mum.
###end p 13
###begin title 14
STIM1 in platelet activation and thrombus formation
###end title 14
###begin p 15
###xml 99 102 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 94 102 94 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 182 190 182 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 330 338 330 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 614 622 607 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 811 814 804 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 806 814 799 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 867 869 860 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 870 871 863 864 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
To test the functional consequences of this defect, we performed ex vivo aggregation studies. Stim1-/- platelets aggregated normally to the G protein-coupled agonists ADP, thrombin (Fig. 2 C), and U46619 (not depicted), even at very low concentrations of these agonists (not depicted). In contrast, responses to collagen and CRP (Fig. 2 C) and the strong GPVI agonist convulxin (not depicted) were significantly diminished. The activation defect was confirmed by flow cytometric analysis of integrin alphaIIbbeta3 activation using the JON/A-PE antibody, and of degranulation-dependent P-selectin surface exposure (Fig. 2 D). Therefore, loss of STIM1-dependent SOCE impairs GPVI-induced integrin activation and degranulation, whereas G protein-coupled agonists are still able to induce normal activation in Stim1-/- platelets in these assays, despite the defect in [Ca2+]i signaling.
###end p 15
###begin p 16
###xml 363 366 363 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 358 366 358 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 497 499 497 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 662 670 662 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 697 700 697 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 692 700 692 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1019 1021 995 997 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
In vivo, platelet activation on the extracellular matrix or a growing thrombus occurs in flowing blood, where locally produced soluble mediators are rapidly cleared. Under these conditions, reduced potency of platelet activators may become limiting, particularly at the high flow rates found in arteries and arterioles. Therefore, we analyzed the ability of Stim1-/- platelets to form thrombi on collagen-coated surfaces in a whole-blood perfusion system (16). Under high shear conditions (1,700 s-1), wild-type platelets adhered to collagen fibers and formed aggregates within 2 min that consistently grew into large thrombi by the end of the perfusion period (Fig. 2 E). In sharp contrast, Stim1-/- platelets exhibited reduced adhesion, and three-dimensional growth of thrombi was markedly impaired. As a consequence, the surface area covered by platelets and the total thrombus volume were reduced approximately42 and approximately81%, respectively. Similar results were obtained at intermediate shear rates (1,000 s-1; not depicted). These findings indicate that STIM1-mediated SOCE is required for efficient platelet activation on collagen and on the surface of growing thrombi under conditions of high shear.
###end p 16
###begin title 17
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 29 37 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Unstable arterial thrombi in Stim1-/- mice
###end title 17
###begin p 18
###xml 482 493 468 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, A&#8211;C</xref>
###xml 587 590 561 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 582 590 556 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 660 663 630 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 655 663 625 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1501 1504 1468 1471 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1496 1504 1463 1471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1563 1578 1530 1545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, D and E</xref>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
Because platelet aggregation may contribute to pathological occlusive thrombus formation, we studied the effects of STIM1 deficiency on ischemia and infarction by in vivo fluorescence microscopy after ferric chloride-induced mesenteric arteriole injury. In all wild-type chimeras, the formation of small aggregates was observed approximately5 min after injury, with progression to complete vessel occlusion in 8 out of 10 mice within 30 min (mean occlusion time = 16.5 +/- 2.8 min; Fig. 3, A-C). In contrast, aggregate formation was significantly delayed in approximately50% of the Stim1-/- chimeras (10.6 +/- 5.8 min in wild-type and 17.1 +/- 7.3 min in Stim1-/- chimeras until the first thrombus >20 mum in diameter appeared; P < 0.05), and formation of stable thrombi was almost completely abrogated. This defect was caused by the release of individual platelets from the surface of the thrombi (Videos 1 and 2, available at ) and not by embolization of large thrombus fragments. Blood flow was maintained throughout the observation period in 9 out of 10 vessels, demonstrating a crucial role for STIM1 during occlusive thrombus formation. This was confirmed in a second arterial thrombosis model in which the abdominal aorta was mechanically injured and blood flow was monitored with an ultrasonic flow probe. Although 10 out of 11 control chimeras formed irreversible occlusions within 16 min (mean occlusion time = 4.4 +/- 4.1 min), occlusive thrombus formation did not occur in 6 out of 8 Stim1-/- chimeras during the 30-min observation period (P < 0.005; Fig. 3, D and E). These results demonstrate that STIM1 is required for the propagation and stabilization of platelet-rich thrombi in small and large arteries, irrespective of the type of injury.
###end p 18
###begin p 19
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">In vivo analysis of thrombosis and hemostasis.</bold>
###xml 97 98 97 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 741 744 739 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 736 744 734 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 905 908 902 905 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 900 908 897 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
In vivo analysis of thrombosis and hemostasis. (A-C) Mesenteric arterioles were treated with FeCl3, and adhesion and thrombus formation of fluorescently labeled platelets were monitored by in vivo video microscopy. Representative images (A), the time to appearance of the first thrombus >20 mum (B), and the time to vessel occlusion (C) are shown. Each symbol represents one individual. The asterisk in A indicates occlusion of the vessel. Horizontal bars in B represent means. Bar, 50 mum. (D and E) The abdominal aorta was mechanically injured, and blood flow was monitored for 30 min or until complete occlusion occurred (blood flow stopped >5 min). (D) Representative cross sections of the abdominal aorta of mice with wild-type or Stim1-/- platelets 30 min after injury. Bar, 250 mum. (E) Time to vessel occlusion. Each symbol represents one individual. (F) Tail bleeding times in wild-type and Stim1-/- chimeras. Each symbol represents one individual. Videos 1 and 2 are available at .
###end p 19
###begin p 20
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 218 221 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 213 221 213 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 295 303 295 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 F</xref>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
To test whether the defect in Stim1-/- platelets impaired hemostasis, we measured tail bleeding times. Although bleeding stopped in 28 out of 30 (93.3%) control mice within 10 min, bleeding was highly variable in Stim1-/- chimeras, with 11 out of 31 (35.5%) mice bleeding for >10 min (P < 0.02; Fig. 3 F). These results show that STIM1 is required for normal hemostasis.
###end p 20
###begin title 21
STIM1 is an essential mediator of ischemic brain infarction
###end title 21
###begin p 22
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 433 436 433 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 428 436 428 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 814 815 814 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 826 829 826 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 821 829 821 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1043 1044 1039 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1058 1066 1054 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 1416 1419 1404 1407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1411 1419 1399 1407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1453 1468 1441 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, B and C</xref>
###xml 1677 1680 1665 1668 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1672 1680 1660 1668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1774 1782 1762 1770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 2055 2063 2043 2051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 2415 2418 2403 2406 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2410 2418 2398 2406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 2429 2437 2417 2425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 E</xref>
###xml 2458 2459 2446 2447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2562 2565 2550 2553 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2557 2565 2545 2553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1521 1525 <span type="species:ncbi:10090">mice</span>
Ischemic stroke is the third leading cause of death and disability in industrialized countries (17). Although it is well established that microvascular integrity is disturbed during cerebral ischemia (18), the signaling cascades involved in intravascular thrombus formation in the brain are poorly understood. To determine the importance of STIM1-dependent SOCE in this process, we studied the development of neuronal damage in Stim1-/- chimeras after transient cerebral ischemia in a model that depends on thrombus formation in microvessels downstream from a middle cerebral artery (MCA) occlusion (19). To initiate transient cerebral ischemia, a thread was advanced through the carotid artery into the MCA and allowed to remain for 1 h (transient MCA occlusion [tMCAO]), reducing regional cerebral flow by >90% (3). In Stim1-/- chimeras, infarct volumes 24 h after reperfusion, as assessed by 2,3,5-triphenyltetrazolium chloride (TTC) staining, were reduced to <30% of the infarct volumes in control chimeras (17 +/- 4.4 vs. 62.9 +/- 19.3 mm3; P < 0.0001; Fig. 4 A). Reductions in infarct size were functionally relevant, as the Bederson score assessing global neurological function (1.86 +/- 0.48 vs. 3.07 +/- 0.35, respectively; P < 0.0001) and the grip test, which specifically measures motor function and coordination (3.71 +/- 0.39 vs. 2 +/- 0.65, respectively; P < 0.0001), were significantly better in Stim1-/- chimeras compared with controls (Fig. 4, B and C). Serial magnetic resonance imaging (MRI) on living mice was used to confirm the protective effect of STIM1 deficiency on infarct development. Hyperintense ischemic infarcts on T2-weighted (T2-w) MRI in Stim1-/- chimeras were <10% of the size of infarcts in control chimeras 24 h after tMCAO (P < 0.0001; Fig. 4 D). Importantly, infarct volume did not increase between days 1 and 7, indicating a sustained protective effect for STIM1 deficiency. Moreover, no intracranial hemorrhage was detected on T2-w gradient echo images, a highly sensitive MRI sequence for the detection of blood (Fig. 4 D), indicating that STIM1 deficiency in hematopoietic cells is not associated with an increase in bleeding complications in the brain. Consistent with the TTC stains and MRI images, histological analysis revealed massive ischemic infarction of the basal ganglia and neocortex in control chimeras but only limited infarction of the basal ganglia in Stim1-/- chimeras (Fig. 4 E). The density of CD3+ T cell and monocyte/macrophage infiltrates in brain infarcts was low, and did not differ between Stim1-/- and control chimeras at 24 h (not depicted).
###end p 22
###begin p 23
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Stim1<sup>&#8722;/&#8722;</sup></italic> chimeras are protected from cerebral ischemia.</bold>
###xml 155 158 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 150 158 150 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 220 223 220 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 215 223 215 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 367 368 367 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 383 386 383 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 378 386 378 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 397 398 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 552 553 550 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 568 571 566 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 563 571 561 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 582 583 580 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 798 801 794 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 793 801 789 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1024 1027 1020 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1019 1027 1015 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1311 1314 1307 1310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1306 1314 1302 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1378 1381 1374 1377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1373 1381 1369 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
Stim1-/- chimeras are protected from cerebral ischemia. (A, left) Representative images of three corresponding coronal sections from control mice and Stim1-/- chimeras stained with TTC 24 h after tMCAO. Infarcts in Stim1-/- chimeras are restricted to the basal ganglia (white arrow), in contrast to controls (black arrows). (right) Brain infarct volumes in controls (n = 7) and Stim1-/- chimeras (n = 7). Values are mean +/- SD. ***, P < 0.0001. Bar, 5 mm. (B and C) Neurological Bederson score and grip test assessed at day 1 after tMACO of controls (n = 7) and Stim1-/- chimeras (n = 7). Values are mean +/- SD. ***, P < 0.0001. (D) The coronal T2-w MR brain image shows a large hyperintense ischemic lesion at day 1 after tMCAO in controls (white arrows; top left). Infarcts are smaller in Stim1-/- chimeras (white arrow; bottom left), and T2 hyperintensity decreases by day 7 during infarct maturation (white arrow; bottom right). Importantly, hypointense areas indicating intracerebral hemorrhage were not seen in Stim1-/- chimeras, demonstrating that Stim1 deficiency does not increase the risk of hemorrhagic transformation, even at advanced stages of infarct development. Bar, 5 mm. (E) Hematoxylin and eosin-stained sections of corresponding territories in the ischemic hemispheres of control and Stim1-/- chimeras. Infarcts are restricted to the basal ganglia in Stim1-/- chimeras but consistently include the cortex in controls. Bars: (left) 200 mum; (right) 50 mum.
###end p 23
###begin p 24
###xml 90 92 90 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 228 230 228 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 596 598 596 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 639 642 639 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 634 642 634 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 704 706 704 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 795 797 795 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 985 987 985 987 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1016 1018 1016 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 1051 1053 1051 1053 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1182 1183 1182 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 1313 1315 1313 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 1317 1319 1317 1319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
STIM1 has been identified as the long-sought calcium sensor that connects intracellular Ca2+ store depletion to the activation of plasma membrane SOC channels in immune cells. Although SOCE is thought to be a major pathway of Ca2+ entry in virtually all nonexcitable cells, this has only been directly shown for T cells (8-10) and IgE-dependent mast cell activation (11). Although STIM1 is highly expressed in platelets (14), the significance of SOCE for platelet function has been unknown because non-SOCE pathways have been described to exist in these cells (20). We found severely defective Ca2+ responses to all major agonists in Stim1-/- platelets, clearly establishing SOCE as the major route of Ca2+ entry in those cells and STIM1 as an essential mediator of this process. The residual Ca2+ influx detected in the mutant cells suggests that other molecules may regulate SOC influx, but only to a minor extent. One candidate molecule is STIM2, which has been shown to activate Ca2+ release-activated channels (21). Alternatively, the residual Ca2+ entry could be mediated by store-independent mechanisms as DAG, and some of its metabolites have been shown to induce non-SOCE (7). In line with this, members of the TRPC family have been suggested as candidates mediating both SOCE and non-SOCE in platelets (15, 20).
###end p 24
###begin p 25
###xml 63 65 63 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 268 276 268 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 E</xref>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 425 427 425 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 632 633 632 633 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 808 810 808 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1023 1025 1023 1025 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Besides the severely impaired SOCE, we also observed reduced Ca2+ release from intracellular stores upon agonist-induced platelet activation, which likely reflects a lower filling state of the SR, as shown by passively emptying the stores with the SERCA inhibitor TG (Fig. 1 E). Similar observations have very recently been reported in mast cells (11), indicating that STIM1 may be involved in the filling of intracellular Ca2+ stores. However, mast cells lacking the major SOC channel Orai1 (22) show normal store content, suggesting a SOC channel-independent role of STIM1 in store refill, possibly through interaction with the IP3 receptors or SERCA pumps in the SR/ER. Because platelets do not have a normal ER, an interesting question is where STIM1 is located in these cells. The major intracellular Ca2+ store seems to be in the so-called dense tubular system, an equivalent of the ER in megakaryocytes. However, lysosome-related (acidic) organelles have been proposed as a second source of intracellularly stored Ca2+ in platelets. Further studies are required to clarify the exact location of STIM1 in platelets.
###end p 25
###begin p 26
###xml 45 47 45 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 261 267 251 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 629 637 615 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 981 983 963 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 1041 1042 1023 1024 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1144 1146 1123 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 1155 1157 1134 1136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1318 1326 1290 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 1364 1365 1336 1337 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1464 1466 1436 1438 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1467 1468 1439 1440 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 1686 1688 1654 1656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1689 1690 1657 1658 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 1829 1832 1793 1796 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1824 1832 1788 1796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1963 1965 1927 1929 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1966 1967 1930 1931 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 2075 2077 2032 2034 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 2107 2109 2064 2066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
Although STIM1 deficiency severely reduced Ca2+ entry in platelets in response to all agonists tested, it did not impair G protein-coupled receptor (GPCR)/PLCbeta-triggered integrin alphaIIbbeta3 activation or release of granule content in the absence of flow (Fig. 2), even at very low agonist concentrations (not depicted). This shows that SOCE is not essential for these processes when the agonist can act on the cells at constant concentrations for a prolonged period of time. In contrast, GPVI/PLCgamma2-induced cellular activation was impaired under these experimental conditions, even at very high agonist concentrations (Fig. 2 C). The reason for this is not clear at present, but it could be related to the fact that GPVI and GPCRs activate different PLC isoforms in platelets. GPVI ligation triggers tyrosine phosphorylation cascades downstream of the receptor-associated immunoreceptor tyrosine-based activation motif (ITAM), culminating in the activation of PLCgamma2 (23), whereas soluble agonists such as thrombin, ADP, and TxA2 stimulate receptors that couple to heterotrimeric G proteins (Gq) and lead to activation of PLCbeta (24). Our Ca2+ measurements show that store release and subsequent SOC influx occur significantly faster upon Gq/PLCbeta stimulation compared with GPVI/PLCgamma2 stimulation (Fig. 2 A), suggesting different kinetics of IP3 production between these two pathways that could influence subsequent events. Clearly, the low [Ca2+]i levels alone cannot explain the defective activation downstream of GPVI/PLCgamma2, as similar or lower levels are seen in response to thrombin and ADP, respectively, without causing this defect. Possibly, elevated [Ca2+]i levels have to act in concert with other transient signals, which may not or no longer be fully present in GPVI/PLCgamma2-stimulated Stim1-/- platelets. This could also explain why platelets expressing an activating EF-hand mutant of STIM1 that leads to elevated basal [Ca2+]i levels display a selective GPVI/PLCgamma2 signaling defect, whereas Gq/PLCbeta-induced store release and Ca2+ entry are largely preserved (14).
###end p 26
###begin p 27
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 48 56 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 214 220 214 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 387 389 387 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">13</sub>
###xml 590 591 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 829 831 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 1036 1039 1036 1039 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1031 1039 1031 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1165 1167 1165 1167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1362 1363 1362 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 1365 1367 1365 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
The rather moderate activation deficits seen in Stim1-/- platelets in the absence of flow translated into severely defective formation of stable three-dimensional thrombi under conditions of medium and high shear (Fig. 3). Such a phenotype has previously been reported in several mice with deficiencies in platelet proteins, including those lacking the heterotrimeric G protein subunit G13 or CD40 ligand, which display marked defects in thrombus stability under flow in vitro and in vivo despite only mild defects in activation/aggregation in the absence of flow (for review see reference 4). This suggests that STIM1-dependent SOCE is particularly important under conditions where agonist potency becomes limiting because of rapid dilution and various stimuli have to be integrated to produce an appropriate cellular response (24). Reduced exposure times rather than low concentrations of these soluble agonists appear to cause the defect under flow, as we observed no reduction in the aggregation response to GPCR activation in Stim1-/- platelets, even at very low agonist concentrations (not depicted). In addition, STIM1 may be involved in the generation of Ca2+ signals downstream of GPIb, which is essential for adhesion and thrombus formation under flow but is not required for the activation and aggregation of platelets in the absence of shear forces (1, 25).
###end p 27
###begin p 28
###xml 209 212 209 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 204 212 204 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 223 229 223 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 739 741 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 945 947 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 969 972 969 972 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 964 972 964 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1116 1122 1116 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 1283 1285 1283 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 1525 1526 1518 1519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 1604 1606 1597 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 811 819 <span type="species:ncbi:9606">patients</span>
###xml 1594 1602 <span type="species:ncbi:9606">patients</span>
###xml 1669 1674 <span type="species:ncbi:10090">mouse</span>
###xml 1726 1731 <span type="species:ncbi:9606">human</span>
Our data indicate that STIM1-dependent SOCE may be of greater relevance for arterial occlusive thrombus formation than for primary hemostasis, though prolonged tail bleeding was observed in a subgroup of Stim1-/- chimeras (Fig. 3). This raises the interesting possibility that hemostasis and thrombosis are mechanistically distinct processes. Therefore, the identification of the mechanisms that trigger pathological thrombus formation but are less essential to arrest bleeding may be the key to the development of safe antithrombotics. This will be of particular importance for the treatment of acute stroke, which is still the third leading cause of death and disability in industrialized countries, with very limited treatment options (17). Numerous attempts to attenuate infarct progression in acute stroke patients by conventional platelet aggregation inhibitors or anticoagulation failed because of an excess of intracerebral hemorrhages (26). We found that Stim1-/- chimeras are protected from neuronal damage after transient cerebral ischemia without displaying an increased risk of intracranial hemorrhage (Fig. 4) despite prolonged tail bleeding times observed in a subgroup of the animals, which confirms that there is no clear correlation between bleeding time and risk (27). These findings are in line with our recent observation that inhibition of the GPIb-GPVI axis is protective in this model, whereas integrin alphaIIbbeta3 (GPIIb/IIIa) inhibition is not but is associated with excess intracranial bleeding (3), which corresponds well with data from clinical studies in stroke patients (26). It is important to note, however, that data obtained in the mouse tMCAO model cannot be directly extrapolated to the human situation, as differences in the pathomechanisms may exist.
###end p 28
###begin p 29
###xml 41 44 41 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 36 44 36 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 400 401 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 403 405 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 626 628 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 630 632 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
Overall, the phenotype of mice with Stim1-/- platelets is similar to that of mice lacking functional GPVI or mice treated with antibodies that block the von Willebrand factor binding site on GPIbalpha, which show severe defects in thrombus formation under flow, protection from arterial thrombus formation, and ischemic brain damage, but which only exhibit a limited risk for bleeding complications (3, 28). This supports the notion that SOCE is particularly important for GPIb-GPVI-ITAM signaling pathways in platelets, which is in line with the well-documented function of STIM1 in ITAM signaling in T cells and mast cells (10, 22).
###end p 29
###begin p 30
Collectively, the results presented in this paper establish STIM1 as an essential mediator of platelet activation that is of critical importance during arterial thrombosis and ischemic brain infarction but not normal hemostasis. These findings may open the way for the development of novel highly effective and safe antithrombotics.
###end p 30
###begin title 31
MATERIALS AND METHODS
###end title 31
###begin title 32
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 32
###begin p 33
###xml 131 134 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 126 134 126 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1</italic>
###xml 413 416 413 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 408 416 408 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>+/&#8722;</sup></italic>
###xml 463 466 463 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 458 466 458 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 740 745 734 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1</italic>
###xml 1346 1348 1334 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 1574 1577 1562 1565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1569 1577 1557 1565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 1643 1644 1631 1632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 1461 1465 <span type="species:ncbi:10090">mice</span>
###xml 1578 1582 <span type="species:ncbi:10090">mice</span>
###xml 1631 1635 <span type="species:ncbi:10090">mice</span>
###xml 1655 1660 <span type="species:ncbi:10090">mouse</span>
Animal studies were approved by the district government of Lower Franconia (Bezirksregierung Unterfranken). The generation of Stim1-/- mice was as follows. A gene trap embryonic stem (ES) cell line containing an insertional disruption in the Stim1 gene (RRS558; clone no. IRAKp961K1818Q; imaGenes) was purchased from BayGenomics. Male chimeras from this ES cell line were bred to C57BL/6 females to generate Stim1+/- mice, which were intercrossed to produce Stim1-/- mice. In the ES cells, the gene trap vector pCMV-SPORT6, which is composed of a splice-acceptor site followed by a "betaGeo" cassette encoding a fusion of beta-galactosidase and neomycin phosphotransferase II, was inserted 600 bp downstream of exon 7, into intron 7 of the Stim1 gene. The integration site was confirmed by PCR and sequencing of the amplified genomic DNA fragment using exon 7 forward (5'-gctgcacaaggcccaggagg-3') and geo1 reverse (5'-atcggcctcaggaagatcgc-3') primers. The transcript would result in the generation of a fusion protein between truncated Stim1 (extracellular region plus transmembrane domain) and beta-galactosidase. This fusion protein was, however, not detectable in platelets by Western blotting using anti-beta-galactosidase antibodies or anti-STIM1 antibodies that recognize the N terminus of the protein (GOK/Stim1, clone 44; BD Bioscience) (11), suggesting that it is rapidly degraded. For the generation of bone marrow chimeras, 5-6-wk-old C57BL/6 female mice were lethally irradiated with a single dose of 10 Gy, and bone marrow cells from 6-wk-old wild-type or Stim1-/- mice were injected intravenously into the irradiated mice (4 x 106 cells per mouse). 4 wk after transplant, platelet counts were determined and STIM1 deficiency was confirmed by Western blotting. All recipient animals received acidified water containing 2 g/liter neomycin sulfate for 6 wk after transplantation.
###end p 33
###begin title 34
Chemicals and antibodies.
###end title 34
###begin p 35
###xml 593 598 <span type="species:ncbi:10090">mouse</span>
Anesthetic drugs used included medetomidine (Pfizer), midazolam (Roche), and fentanyl (Janssen-Cilag GmbH). For antagonists, atipamezol (Pfizer) and flumazenil and naloxon (both purchased from Delta Select GmbH) were used according to local authority regulations. ADP (Sigma-Aldrich), U46619 (Qbiogene), thrombin (Roche), collagen (Kollagenreagent Horm; Nycomed), and TG (Invitrogen) were purchased as indicated. Monoclonal antibodies conjugated to FITC or PE, or DyLight 488 were obtained from Emfret Analytics. The JON/A-PE antibody preferentially binds to the high affinity conformation of mouse integrin alphaIIbbeta3 (Emfret Analytics). Anti-STIM1 monoclonal antibodies were purchased from BD Biosciences (GOK/Stim1, clone 44) and Abnova (clone 5A2).
###end p 35
###begin title 36
Intracellular calcium measurements.
###end title 36
###begin p 37
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 402 404 394 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
Platelet intracellular calcium measurements were performed as previously described (29). In brief, platelets isolated from blood were washed, suspended in Tyrode's buffer without calcium, and loaded with 5 muM Fura-2/AM in the presence of 0.2 mug/ml Pluronic F-127 (Invitrogen) for 30 min at 37degreesC. After labeling, platelets were washed once and resuspended in Tyrode's buffer containing 0.5 mM Ca2+ or 1 mM EGTA. Stirred platelets were activated with agonists, and fluorescence was measured with a fluorimeter (LS 55; PerkinElmer). Excitation was alternated between 340 and 380 nm, and emission was measured at 509 nm. Each measurement was calibrated using Triton X-100 and EGTA.
###end p 37
###begin title 38
Platelet aggregation and flow cytometry.
###end title 38
###begin p 39
###xml 39 40 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 99 104 <span type="species:ncbi:9606">human</span>
Washed platelets (200 mul with 0.5 x 106 platelets/mul) were analyzed in the presence of 70 mug/ml human fibrinogen. Transmission was recorded on a four-channel aggregometer (Fibrintimer; APACT) for 10 minutes and was expressed in arbitrary units, with buffer representing 100% transmission. For flow cytometry, heparinized whole blood was diluted 1:20 and incubated with the appropriate fluorophore-conjugated monoclonal antibodies for 15 min at room temperature and analyzed on a FACSCalibur (Becton Dickinson).
###end p 39
###begin title 40
Adhesion under flow conditions.
###end title 40
###begin p 41
###xml 304 306 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
Rectangular coverslips (24 x 60 mm) were coated with 0.2 mg/ml fibrillar type I collagen (Nycomed) for 1 h at 37degreesC and blocked with 1% BSA. Heparinized whole blood was labeled with a DyLight 488-conjugated anti-GPIX Ig derivative at 0.2 mug/ml, and perfusion was performed as previously described (16). Image analysis was performed off-line using Metavue software (Visitron). Thrombus formation was expressed as the mean percentage of total area covered by thrombi, and as the mean integrated fluorescence intensity per square millimeter.
###end p 41
###begin title 42
Bleeding time.
###end title 42
###begin p 43
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were anesthetized and a 3-mm segment of the tail tip was removed with a scalpel. Tail bleeding was monitored by gently absorbing blood with filter paper at 20-s intervals without making contact with the wound site. When no blood was observed on the paper, bleeding was determined to have ceased. Experiments were stopped after 20 min.
###end p 43
###begin title 44
###xml 51 52 51 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Intravital microscopy of thrombus formation in FeCl3-injured mesenteric arterioles.
###end title 44
###begin p 45
###xml 469 470 468 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 507 508 506 507 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
4 wk after bone marrow transplantations, chimeras were anesthetized and the mesentery was exteriorized through a midline abdominal incision. 35-60-mum-diameter arterioles were visualized at 10x with an inverted microscope (Axiovert 200; Carl Zeiss, Inc.) equipped with a 100-W HBO fluorescent lamp source and a camera (CoolSNAP-EZ; Visitron). Digital images were recorded and analyzed off-line using Metavue software. Injury was induced by topical application of a 3-mm2 filter paper saturated with 20% FeCl3 for 10 s. Adhesion and aggregation of fluorescently labeled platelets (DyLight 488-conjugated anti-GPIX Ig derivative) in arterioles was monitored for 30 min or until complete occlusion occurred (blood flow stopped for >1 min).
###end p 45
###begin title 46
Aorta occlusion model.
###end title 46
###begin p 47
###xml 83 87 <span type="species:ncbi:10090">mice</span>
A longitudinal incision was performed to open the abdominal cavity of anesthetized mice and expose the abdominal aorta. An ultrasonic flow probe was placed around the vessel, and thrombosis was induced by a single firm compression with a forceps. Blood flow was monitored until complete occlusion occurred or 30 min had elapsed.
###end p 47
###begin title 48
MCA occlusion model.
###end title 48
###begin p 49
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 43 51 43 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 598 599 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 745 746 745 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
Experiments were conducted on 10-12-wk-old Stim1-/- or control chimeras according to previously published recommendations for research in mechanism-driven basic stroke studies (30). tMCAO was induced under inhalation anesthesia using the intraluminal filament (Doccol Company) technique (3). After 60 min, the filament was withdrawn to allow reperfusion. For measurements of ischemic brain volume, animals were killed 24 h after induction of tMCAO, and brain sections were stained with 2% TTC (Sigma-Aldrich). Brain infarct volumes were calculated and corrected for edema, as previously described (3). Neurological function and motor function were assessed by two independent and blinded investigators 24 h after tMACO, as previously described (3).
###end p 49
###begin title 50
Assessment of infarction and hemorrhage by MRI.
###end title 50
###begin p 51
MRI was performed 24 h and 7 d after transient ischemia on a 1.5 T unit (Vision; Siemens) under inhalation anesthesia. A custom-made dual-channel surface coil was used for all measurements (A063HACG; Rapid Biomedical). The MR protocol included a coronal T2-w sequence (slice thickness = 2 mm) and a coronal T2-w gradient echo constructed interference in steady state (CISS) sequence (slice thickness = 1 mm). MR images were transferred to an external workstation (Leonardo; Siemens) for data processing. The visual analysis of infarct morphology and the search for eventual intracerebral hemorrhage were performed in a blinded manner. Infarct volumes were calculated by planimetry of hyperintense areas on high resolution CISS images.
###end p 51
###begin title 52
Histology.
###end title 52
###begin p 53
Formalin-fixed brains embedded in paraffin (HistoLab) were cut into 4-mum-thick sections and mounted. After removal of paraffin, tissues were stained with hematoxylin and eosin (Sigma-Aldrich).
###end p 53
###begin title 54
Statistics.
###end title 54
###begin p 55
###xml 120 123 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 115 123 113 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
###xml 173 174 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 420 421 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Results from at least three experiments per group are presented as means +/- SD. Differences between wild-type and Stim1-/- groups were assessed by the two-tailed Student's t test. For the stroke model, results are presented as means +/- SD. Infarct volumes and functional data were tested for Gaussian distribution with the D'Agostino and Pearson omnibus normality test and then analyzed using the two-tailed Student's t test. For statistical analysis, PrismGraph 4.0 software (GraphPad Software, Inc.) was used. P < 0.05 was considered statistically significant.
###end p 55
###begin title 56
Online supplemental material.
###end title 56
###begin p 57
###xml 103 106 103 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 98 106 98 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stim1<sup>&#8722;/&#8722;</sup></italic>
Videos 1 and 2 show representative time-lapse videos of in vivo thrombus formation in control and Stim1-/- chimeras. Online supplemental material is available at .
###end p 57
###begin title 58
Supplementary Material
###end title 58
###begin title 59
[Supplemental Material Index]
###end title 59
###begin p 60
###xml 58 62 <span type="species:ncbi:10090">mice</span>
We thank Michael Bosl for help with the generation of the mice, Ronmy Rivera Galdos and Madeleine Austinat for histology, and David Gailani for critically reading the manuscript.
###end p 60
###begin p 61
This work was supported by the Rudolf Virchow Center and the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 688, A1 and B1, and grant Ni556/7-1 to B. Nieswandt).
###end p 61
###begin p 62
The authors declare that they have no competing financial interests.
###end p 62

